This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rüppel, R. Articles by Cappato, R. Search for Related Content PubMed PubMed Citation Articles by Rüppel, R. Articles by Cappato, R.

CLINICAL STUDIES

Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators

^a University Hospital Eppendorf, Hamburg, Germany
^* Saint Georg Hospital, Hamburg, Germany

Manuscript received October 17, 1997; revised manuscript received July 27, 1998, accepted July 29, 1998.

Address for correspondence: Dr. Riccardo Cappato, II. Med. Abteilung, AK Saint Georg, Lohmühlenstrasse 5, 20099 Hamburg, Germany
R_Cappato{at}magicvillage.de

Objective. The purpose of this study was to use the electrogram storage capabilities of the implantable cardioverter-defibrillator (ICD) to categorize any arrhythmic event during follow-up in a group of patients who had survived an episode of ventricular fibrillation (VF) and to possibly identify clinical predictors of future arrhythmic events.

Background. Little is known about the electrophysiologic characteristics of ventricular arrhythmias recurring during follow-up in survivors of VF as the sole documented arrhythmia at the time of resuscitation.

Methods. Forty patients (58 ± 10 years; 73% men; left ventricular ejection fraction 42 ± 18%; 70% with coronary artery disease) who had survived an episode of VF and subsequently received an ICD capable of intracardiac electrogram recording and storage were followed for 23 ± 11 months. In all patients, the arrhythmogenic substrate was investigated by means of programmed electrical stimulation (PES).

Results. Among the 40 patients, 41 episodes of ventricular arrhythmias were documented in 13 patients (33%): 36 episodes of ventricular tachycardias (VT) were recorded in 11 patients (28%) and 5 episodes of VF were recorded in the remaining 2 patients (5%). Age, gender, cardiac disease and left ventricular ejection fraction failed to distinguish between patients with clinical recurrences and patients without. The sensitivity, specificity and positive accuracy of PES were 29%, 63% and 46%, respectively, for prediction of ventricular arrhythmia recurrence; 45%, 70% and 36%, respectively, for prediction of VT; and 50%, 98% and 50%, respectively, for prediction of VF during follow-up.

Conclusions. In survivors of VF receiving ICD therapy, VT is the most common ventricular arrhythmia recorded on device-incorporated electrograms during follow-up. This finding, associated with the relatively well-preserved ventricular function, may account for the ability of these patients to survive at time of the index arrhythmia; the use of antitachycardia pacing as a modality to treat arrhythmia recurrences may contribute to reduce the incidence of shock during follow-up in these patients.

Abbreviations and Acronyms   AV = atrioventricular   CAD = coronary artery disease   ICD = implantable cardioverter-defibrillator   PES = programmed electrical stimulation   VF = ventricular fibrillation   VT = ventricular tachycardia

This article has been cited by other articles:

				C. J. McLeod, S. R. Ommen, M. J. Ackerman, P. L. Weivoda, W. K. Shen, J. A. Dearani, H. V. Schaff, A. J. Tajik, and B. J. Gersh Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur. Heart J., November 1, 2007; 28(21): 2583 - 2588. [Abstract] [Full Text] [PDF]

				R. Lampert, C. A. McPherson, J. F. Clancy, T. L. Caulin-Glaser, L. E. Rosenfeld, and W. P. Batsford Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2293 - 2299. [Abstract] [Full Text] [PDF]

				C Wolpert, J Kuschyk, N Aramin, S Spehl, F Streitner, T Suselbeck, B Schumacher, K K Haase, R Schimpf, and M Borggrefe Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator Heart, June 1, 2004; 90(6): 667 - 671. [Abstract] [Full Text] [PDF]

				P Mazeika Aborted sudden cardiac death: a clinical perspective Postgrad. Med. J., June 1, 2001; 77(908): 363 - 370. [Abstract] [Full Text]

				G. Gronefeld and S. H Hohnloser What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death? Cardiovasc Res, May 1, 2001; 50(2): 232 - 241. [Abstract] [Full Text] [PDF]

				S. Nisam A Prophylactic ICD? Who are the patients? What is the device? Europace, January 1, 2001; 3(4): 269 - 274. [PDF]

				B. J. Maron, W.-K. Shen, M. S. Link, A. E. Epstein, A. K. Almquist, J. P. Daubert, G. H. Bardy, S. Favale, R. F. Rea, G. Boriani, et al. Efficacy of Implantable Cardioverter-Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy N. Engl. J. Med., February 10, 2000; 342(6): 365 - 373. [Abstract] [Full Text] [PDF]